Drug Discovery

GLP-1 Drugs Reduce Post-Surgical Complications in Diabetic Patients
Research & Development GLP-1 Drugs Reduce Post-Surgical Complications in Diabetic Patients

In a transformative study examining the impact of GLP-1 receptor agonist drugs on post-surgical outcomes for diabetic patients, researchers have discovered significant reductions in post-surgical complications when these medications are part of the regimen. Drugs like tirzepatide and semaglutide,

NUS Pioneers Magnetic Fields to Enhance Chemotherapy for Breast Cancer
Research & Development NUS Pioneers Magnetic Fields to Enhance Chemotherapy for Breast Cancer

Researchers at the National University of Singapore (NUS) have developed an innovative method to enhance the effectiveness of chemotherapy while mitigating its adverse side effects. This novel approach employs brief, localized pulses of magnetic fields, which significantly increase the uptake of

How AI is Revolutionizing Drug Discovery and Development for Better Health
Research & Development How AI is Revolutionizing Drug Discovery and Development for Better Health

Artificial Intelligence (AI) is making significant strides in various fields, and drug development is no exception. While AI's applications in text generation, facial recognition, and autonomous driving are well-known, its potential in drug discovery is equally transformative, promising to

Can AI Truly Revolutionize Drug Discovery and Development?
Research & Development Can AI Truly Revolutionize Drug Discovery and Development?

The role of artificial intelligence (AI) in drug discovery and development has been a topic of increasing interest and debate, with many experts heralding its promise to transform the process by reducing time and costs significantly. Amid the excitement, however, there remain substantial challenges

Can mRNA Vaccines Revolutionize Pancreatic Cancer Treatment?
Research & Development Can mRNA Vaccines Revolutionize Pancreatic Cancer Treatment?

The groundbreaking exploration of mRNA vaccines, most notably recognized for their pivotal role in combating the COVID-19 pandemic, has far-reaching implications that extend beyond infectious disease management into the realm of oncology. Researchers at Memorial Sloan Kettering Cancer Center

Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279
Research & Development Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279

Psoriasis, often misunderstood as merely a skin condition, is a complex immune-mediated disease impacting around 125 million individuals globally. This systemic condition demands comprehensive treatment strategies that go beyond addressing superficial skin symptoms. Dr. Graham Heap, Vice President

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later